PositoAI

a positivity index

Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights

Latest News

TransCode Therapeutics, Inc.

TransCode Therapeutics, Inc. Estimates – NASDAQ:RNAZ
TradingView · 23 Oct 2026
TransCode Therapeutics to Present Updated Phase 1a TTX-MC138 Data at ESMO Congress 2026
citybuzz - · 19 Oct 2026
NetworkNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) to Present Updated Phase 1a TTX-MC138 Clinical Data at ESMO Congress 2026
StreetInsider · 19 Oct 2026
TransCode to present Phase 1a trial results of cancer drug TTX-MC138 at ESMO 2026 in Madrid
Pluang · 19 Oct 2026
Transcode Therapeutics, Inc. Presents Phase 1A Clinical Trial Data for Ttx-Mc138 At Esmo Congress 2026
www.marketscreener.com · 19 Oct 2026
TransCode Therapeutics to Present Phase 1a Clinical Trial Data for TTX-MC138 at ESMO Congress 2026
PR Newswire · 19 Oct 2026
Natera to Provide MRD Testing for TransCode Therapeutics CRC Trial Recruitment
GenomeWeb · 13 Oct 2026
Form 8K Transcode Therapeutics Inc For: 1 October By Investing.com
Investing.com India · 02 Oct 2026
TransCode Reports Continued Disease Stabilization and Extended Treatment Duration with TTX-MC138 in Ongoing Phase 1a Clinical Trial Follow-Up
PR Newswire · 28 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.